Latest Lonza News & Updates

See the latest news and media coverage for Lonza. We track all announcements, press releases, and industry mentions in real time, all in one place.

Lonza

Dedicated CDMO serving the healthcare industry

lonza.com

Headquarters: Basel, Switzerland
Founded year: 1897
Company type: Public company
Number of employees: 15,000+

Last updated Today

Latest news about Lonza

In short: Lonza transitioned to a pure-play CDMO by divesting its Capsules & Health Ingredients business and reporting strong Q1 2026 financial performance.

Company announcements

June 15 Lonza

Lonza grants exclusive license to Antharis Therapeutics for dual-payload ADCs

The target-specific agreement enables Antharis to develop next-generation ADCs for gastrointestinal cancers using Lonza's site-specific ADC technologies.

June 9 Lonza

Lonza appoints Hans Trees as Global Head of Communications

He will join on 1 September 2026, succeeding David Carter, and brings experience from Roche.

June 2 Lonza

Lonza announces enhanced DNA-to-IND biologics development offering

The offering includes early de-risking, accelerated timelines, and new GS Ori-Go vector technology for higher titers.

May 12 Lonza

Lonza launches Xcite AAV stable producer cell line platform

New technology demonstrates superior performance and scalability for viral vector manufacturing.

Media coverage

June 9 AD HOC NEWS

Lonza Group AG stock (CH0013841017): Strategy update and pipeline focus after recent newsflow

Lonza Group AG remains in focus as investors digest recent strategy updates, capacity investments and pipeline developments in its biologics and small-molecule manufacturing business. The...

June 2 Finanzen.ch

Lonza Stock News: Lonza up in the morning

Among the winners of the day on Tuesday morning is Lonza's stock. The Lonza stock has recently gained in SIX SX trading and rose by 0.9...

June 1 Nutritional Outlook

Lonza Launches Vegetarian DHA Omega-3 | Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends

Lonza's algae-derived DHAid line includes both oil and powdered products.

May 28 cash

Lonza share on the verge of meteoric rise according to ZKB

Lonza shares continue to stagnate. On Thursday they fell 1.27 percent to 490.50 francs. So they are still moving...

Never miss news about Lonza

Track Lonza and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Lonza competitors & trending companies

Browse news for competitors to Lonza and other trending companies.